Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration

被引：0
|
作者：
J B Jonas
U H Spandau
B A Kamppeter
B Harder
机构：
[1] Faculty of Clinical Medicine Mannheim of the University Heidelberg,Department of Ophthalmology
来源：
Eye | 2007年 / 21卷
关键词：
intravitreal triamcinolone acetonide; intravitreal steroids; age-related macular degeneration; intraocular neovascularization; macular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [1] Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration
    Jonas, J. B.
    Spandau, U. H.
    Kamppeter, B. A.
    Harder, B.
    EYE, 2007, 21 (03) : 387 - 394
  • [2] Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration
    Jonas, Jost B.
    Spandau, Ulrich H.
    Kamppeter, Bernd A.
    Vossmerbaeumer, Urs
    Harder, Bjoern
    OPHTHALMIC RESEARCH, 2006, 38 (06) : 324 - 328
  • [3] Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration
    Jonas, Jost B.
    Ihloff, Anna K.
    Harder, Bjoern
    Kreissig, Ingrid
    Schlichtenbrede, Frank
    Libondi, Teodosio
    Spandau, Ulrich H. M.
    Vossmerbaeumer, Urs
    OPHTHALMIC RESEARCH, 2009, 41 (01) : 21 - 27
  • [4] Intravitreal Bevacizumab After Intravitreal Triamcinolone for Exudative Age-Related Macular Degeneration
    Jonas, Jost B.
    Libondi, Teodosio
    Golubkina, Lidia
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2012, 1 (03): : 140 - 141
  • [5] Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients
    Ito, M
    Okubo, A
    Sonoda, Y
    Yamakiri, K
    Sakamoto, T
    OPHTHALMOLOGICA, 2006, 220 (02) : 118 - 124
  • [6] Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study
    J B Jonas
    R F Degenring
    I Kreissig
    T Friedemann
    I Akkoyun
    Eye, 2005, 19 : 163 - 170
  • [7] Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study
    Jonas, JB
    Degenring, RF
    Kreissig, I
    Friedemann, T
    Akkoyun, I
    EYE, 2005, 19 (02) : 163 - 170
  • [8] Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
    Becerra, E. M.
    Morescalchi, F.
    Gandolfo, F.
    Danzi, P.
    Nascimbeni, G.
    Arcidiacono, B.
    Semeraro, F.
    CURRENT DRUG TARGETS, 2011, 12 (02) : 149 - 172
  • [9] Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration
    Sutter, F. K.
    Kurz-Levin, M. M.
    Scherrer, M.
    Barthelmes, D.
    Fleischhauer, J. C.
    Helbig, H.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (04) : 297 - 299
  • [10] Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration
    Jonas, Jost B.
    Libondi, Teodosio
    Golubkina, Lidia
    Spandau, Ulrich H.
    Schlichtenbrede, Frank
    Rensch, Florian
    ACTA OPHTHALMOLOGICA, 2010, 88 (06) : 630 - 634
12345